KAKEN PHARMACEUTICAL
Kaken Pharmaceutical is a specialty pharmaceutical company that develops and commercializes novel pharmaceuticals and medical devices.
KAKEN PHARMACEUTICAL
Social Links:
Industry:
Health Care Manufacturing Medical Device Pharmaceutical
Founded:
1948-03-01
Status:
Active
Contact:
81-3-5977-5002
Technology used in webpage:
Apple Mobile Web Clips Icon Apache Apache 2.4 OpenSSL GlobalSign GlobalSign Domain Verification Red Hat Enterprise Linux Internap
Similar Organizations
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Kilitch Drugs
Kilitch Drugs is a Pharma Company that provides like Parenteral solutions, Effervescent, Nutritional Products & Medical devices.
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Synmosa Biopharma
Synmosa is a specialty pharmaceutical corporation that engages in diversified development that includes acting as an agent, manufacturing.
Well Pharmaceutical
Well Pharmaceutical is a supplier of pharmaceutical excipients and high-end lubricant base oils and special surfactants.
Zhejiang Jingxin Pharmaceutical
Zhejiang Jingxin Pharmaceutical is a listed pharmaceutical company integrating R&D, production and sales.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-30 | ARTham Therapeutics | ARTham Therapeutics acquired by Kaken Pharmaceutical | 5.5 B JPY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-01-29 | GENEX | Kaken Pharmaceutical investment in Seed Round - GENEX | N/A |
More informations about "Kaken Pharmaceutical"
KAKEN at a Glance | KAKEN PHARMACEUTICAL CO., LTD.
Kaken Pharmaceutical (KAKEN) is an R&D-driven pharmaceutical company that was established after the reorganization of the Institute of Physical and Chemical Research (Riken) in 1948. To โฆSee details»
KAKEN PHARMACEUTICAL CO., LTD. | Member Companies | Japan ...
This page is a KAKEN PHARMACEUTICAL CO., LTD. page of JPMA. Address: 2-28-8 Honkomagome, Bunkyo-ku, Tokyo 113-8650. Contact: Phone๏ผ+81-3-5977-5046See details»
KAKEN Pharmaceutical Co., Ltd. - eu-japan.eu
2 BUSINESS DEVELOPMENT Medical Device 10.9% Agro-veterinary 5.5% Pharmaceuticals 78.8% Others 4.8% Head Office๏ผTokyo, Japan Founded: March 1, 1948 Employees: 1,397 โฆSee details»
Organization | Kaken Pharmaceutical Co.,Ltd.
Kaken Pharmaceutical Co.,Ltd. Report issue For profit Phase 2 Phase 3 Founded: Tokyo Japan (1948)See details»
Kaken Pharmaceutical Company Description - Stock Analysis
Aug 28, 2023 The company offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Fiblast, a โฆSee details»
About KAKEN | KAKEN PHARMACEUTICAL CO., LTD.
About KAKEN of Kaken Pharmaceutical Co.,Ltd.See details»
Johnson & Johnson, Kaken Pharmaceutical Strike Licensing โฆ
Jan 3, 2025 Additionally, Kaken will be eligible to receive an equity investment from Johnson & Johnson InnovationโJJDC, Inc.โthe venture capital organization of Johnson & Johnson. 1. โฆSee details»
Management Team | KAKEN โฆ
Director, Pharmaceutical Common Achievement Tests Organization (to present) Oct. 2018: Board Member, Japan Society for Pharmaceutical Education (to present) Apr. 2023: โฆSee details»
Kaken Pharmaceutical - Crunchbase Investor Profile
Kaken Pharmaceutical produces and supplies agrochemicals, feed additives, and veterinary drugs. They also offer pesticides such as horticultural fungicide, lawn fungicide, acaricide, box application agents for paddy rice, temacat โฆSee details»
Johnson & Johnson to license novel oral assets, further โฆ
Dec 26, 2024 The Company is licensing a STAT6 program from Kaken Pharmaceutical that targets a clinically relevant pathway in atopic dermatitis as well as other autoimmune and โฆSee details»
JnJ enters licensing agreement for global development, โฆ
Dec 27, 2024 Kaken will retain the commercialization rights in Japan, where Johnson & Johnson will have an option to enter into a co-promotion agreement with Kaken. Separately, Kaken is โฆSee details»
Mission Statement, Vision, & Core Values (2024) of Kaken โฆ
[relinking] Home Overview Mission Vision Values An Overview of Kaken Pharmaceutical Co., Ltd.General Summary of Kaken Pharmaceutical Co., Ltd. Kaken Pharmaceutical Co., Ltd. was โฆSee details»
J&J Bags Kakenโs STAT6 Inhibitor, Set to Take 6% Stake in Japan Firm
Dec 26, 2024 Kaken Pharmaceutical said on December 26 that it is out-licensing its STAT6 program, including the preclinical oral agent KP-723 for Type 2 inflammatory diseases, to โฆSee details»
Kaken Pharmaceutical - Craft
Oct 29, 2024 Kaken Pharmaceutical is a company focusing on the development and commercialization of pharmaceuticals and medical devices in the orthopedics and โฆSee details»
STAT6 inhibitors (Kaken) - Drug Targets, Indications, Patents
Dec 5, 2024 We tested three bilaterally established lung cancer murine models: Lewis lung carcinoma in B6.Foxp3 EGFP mice, and 344SQ-parental or 344SQ anti-PD1-resistant โฆSee details»
Operational excellence in biopharma research and early โฆ
1 day ago Organizations can accelerate research and early development by systematically mapping key processes such as pharmaceutical sciences, research, writing, and regulatory โฆSee details»
Development Pipeline | KAKEN PHARMACEUTICAL CO., LTD.
May 14, 2024 Development Pipeline of Kaken Pharmaceutical Co.,Ltd. Development Code Planned Indication Development Stage Notes; KAR: Head lice: Phase โ ขSee details»
Pharmaceuticals Business | KAKEN PHARMACEUTICAL CO., LTD.
Pharmaceuticals Business of Kaken Pharmaceutical Co.,Ltd. Message from the President. Long-Term Business PlanSee details»
Investor Relations | KAKEN PHARMACEUTICAL CO., LTD.
Investor Relations of Kaken Pharmaceutical Co.,Ltd. Message from the President. Long-Term Business PlanSee details»